The American Heart Association and the American the College of Cardiology in 2025 issued guidelines to help reduce ...

Although Canada historically has been a leader in hypertension treatment and control, rates have declined in the past decade, particularly among women and vulnerable groups. With the aim of improving ...

The management of hypertension has historically been shaped by two competing schools of thought. The first posits that reducing blood pressure itself is the ultimate priority, with clinical benefits ...

Hypertension is one of the most common chronic conditions in the U.S., affecting nearly half of the country’s adults, according to the Centers for Disease Control and Prevention. Unfortunately, ...

Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist ...

Please provide your email address to receive an email when new articles are posted on . There is generally high awareness surrounding the 2022 guidelines for pulmonary hypertension, although some gaps ...

A call to include recommendations on low-sodium potassium-enriched salt in hypertension treatment guidelines has been made by an international group of experts today in the American Heart ...

The FDA has issued a complete response letter for an oral selective glucocorticoid receptor antagonist under investigation ...

There was a steady increase in the prevalence of chronic hypertension in pregnancy over the last two decades, with some accompanying changes in treatment, a nationwide cohort study found. From 2008 to ...